Haemonetics Corporation
$5.68B- Market cap
- $4.68B
- Debt
- +$1.24B
- Cash
- −$245.44M
Capital structure 79% equity / 21% debt · EV / Revenue 4.26x · EV / EBITDA 21.58x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
HAE · current priceP/E 50.20x
$102.92Latest market snapshot
Implied fair value · at CAH's multiple
$70.0931.9% below market
2.05 HAE EPS (TTM)×34.19x CAH P/E=$70.09
Market $102.92Implied $70.09
CAH · current priceP/E 34.19x
$247.18Latest market snapshot
Implied fair value · at HAE's multiple
$362.9846.8% above market
7.23 CAH EPS (TTM)×50.20x HAE P/E=$362.98
Market $247.18Implied $362.98